Working side-by-side with our clients, we leverage every possible IP-related opportunity to maximize revenue and accomplish their business objectives.
Who we are
Intellectual property laws, and the competitive landscape in many industries, are shifting rapidly. Now more than ever, attorneys need to bring not only sharp legal skills, but also a deep knowledge of technology, and excellent industry-specific business judgment to every matter.
There are few assets more valuable than your intellectual property. Effective navigation in an increasingly competitive market has never been more important. Protecting your innovations and minimizing costly disputes and interruptions to your business are essential to generate revenue and stay a step ahead of your competition.
We understand that our clients’ innovations serve as the foundation for building strong companies and reputations. We help clients stay abreast of the ever-changing U.S. patent system, monitor rapidly shifting social media trends that impact our clients’ brands, intimately understand our clients’ competitive landscape, and vigorously defend our clients’ IP rights.
Who we work with
- Cutting edge technology companies
- Consumer product and services companies
- Life science companies
- Leading universities and academic medical centers
- Optics firm taking Chinese manufacturers to task
Democrat & Chronicle | September 18, 2014
Rochester IP Counseling & Transactions partner Kristen Walsh is quoted in this article on IP issues for U.S. companies operating, or considering starting operations, in China.
- Antique Car Dealer Taking the Low Road by Infringing Songs, Suit Says
Westlaw Journal | September 8, 2014
This coverage highlights Freeplay Music Inc. v. Streetside Classics—a lawsuit over alleged use of copyrighted songs. Partner and leader of the IP Litigation practice Jason Kravitz and Long Island Commercial Litigation associate Seth Berman are noted as plaintiffs’ counsel.
- The Past, Present and Future of Stem Cells
Daily Journal | August 27, 2014
Los Angeles office managing partner Seth Levy and Los Angeles patent agent Stephen Chen co-authored this column looking at the state of stem cells and what’s next.